The Council for Innovation Promotion (C4IP) submitted its comments on the recent Listening Sessions hosted by the Federal Trade Commission (FTC) and Department of Justice (DOJ) on lowering drug prices in an August 15 letter addressed to Meredyth Andrus, an attorney in the Health Care Division, Bureau of Competition, at the FTC.
Recent Posts
- Other Barks & Bites for Friday, November 7: CJEU Action Against EU Commission Referred Over SEP Regulation; Ninth Circuit Affirms CoComelon Copyright Win; and C4IP Urges USTR to Address IP Concerns in USMCA Joint Review
- Mixed UK High Court Ruling Fails to Answer Fundamental Questions of AI Copyright Infringement
- Professors Press SCOTUS to Affirm Copyright Protection for AI-Created Works
- Squires Emphasizes AI, Dubs Inherited Backlog ‘An Absolute Dumpster Fire’ and a ‘Betrayal’
- Federal Circuit Clarifies Precedent on Pre-AIA Prior Art ‘By Another’